My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
This functionality will provide users with ease of access navigation and enable create a new revenue line by generating leads of potential customers for brokers in a more integrated manner.
Brokerage house Ajcon Global is bullish on Bharat Immunologicals and has recommended buy rating on the stock with a target price of Rs 600 in its research report dated March 19, 2015.
You are already a Moneycontrol Pro user.